Carefusion Corp. Earnings Cheat Sheet: Profit Rises Year Over Year

Falling revenue did not prevent S&P 500 (NYSE:SPY) component Carefusion Corporation (NYSE:CFN) from reporting a profit boost in the fourth quarter. CareFusion Corp is a medical technology company offering clinically proven products and services designed to improve the safety and quality of healthcare.

Investing Insights: Steve Jobs Prepares to Deliver a New Catalyst for Apple’s Stock >>

Carefusion Earnings Cheat Sheet for the Fourth Quarter

Results: Net income for the medical instruments and supplies company rose to $85 million (37 cents per share) vs. $52 million (23 cents per share) in the same quarter a year earlier. This marks a rise of 63.5% from the year earlier quarter.

Revenue: Rose 3.7% to $964 million from the year earlier quarter.

Actual vs. Wall St. Expectations: CFN reported adjusted income from continuing operations of 52 cents per share. By that measure, the company beat the mean analyst estimate of 50 cents per share. Analysts were expecting revenue of $967.2 million.

Quoting Management: “Growth in our Infusion, Dispensing and Infection Prevention businesses, gross margin expansion and the benefit of strong spending controls drove double digit improvements in our adjusted operating earnings for the quarter and for the year,” said Kieran Gallahue, chairman and CEO. “We continue to make progress in optimizing our product portfolio and expanding our geographical footprint. We recently acquired pharmacy automation innovator Rowa, enabling us to expand our Pyxis platform outside the U.S.”

Competitors to Watch: Teleflex Incorporated (NYSE:TFX), Covidien plc (NYSE:COV), Thermo Fisher Scientific Inc. (NYSE:TMO), Cardinal Health, Inc. (NYSE:CAH), Masimo Corporation (NASDAQ:MASI), Angeion Corporation (NASDAQ:ANGN), NeuroMetrix, Inc. (NASDAQ:NURO), Baxter International Inc. (NYSE:BAX), C.R. Bard, Inc. (NYSE:BCR), and Stryker Corporation (NYSE:SYK).

Investing Insights: Steve Jobs Prepares to Deliver a New Catalyst for Apple’s Stock >>

(Source: Xignite Financials)